Type 1 Kounis syndrome: recurrent myocardial infarctions in a patient with aspirin-exacerbated respiratory disease: a case report

Introduction. We present a case of type 1 Kounis syndrome in a patient with recurrent myocardial infarction with non-obstructive coronary arteries (MINOCA) due to allergic coronary vasospasm. Awareness of doctors about this pathology will allow identifying the MINOCA causes and prescribing pathogenetic treatment.

Brief description. A 51-year-old woman with aspirin-exacerbated respiratory disease (asthma, rhinosinusitis with nasal polyposis, aspirin hypersensitivity, eosinophilia) without cardiovascular risk factors developed three recurrent myocardial infarctions against the background of vasospastic angina over a 6-month period. Despite the typical clinical performance, stable ST segment elevation, unchanged coronary arteries on coronary angiography, the vasospastic MI was not immediately established. The patient received long-term treatment for type 1 MI, including beta-blockers. Recurrent MI occurred against the background of an asthma attack. During the second and third hospitalization for MI, coronary angiography revealed a spasm of the right coronary artery, which completely resolved with the nitroglycerin administration. Intracoronary ultrasound made it possible to rule out atherosclerotic involvement of the infarct-related artery. Subsequently, microvascular angina developed, which was confirmed by positron emission tomography. Vasospastic angina in combination with microvascular angina, MIBOCA with asthma attacks, were regarded as type 1 Kounis syndrome. Over the next 2 years, the patient received pathogenetic treatment, and no recurrent cardiovascular events were observed.

Discussion. Lack of awareness about Kounis syndrome led to incomplete examination of the patient with MIBOCA and the prescription of pathogenetically unreasonable tehrapy, which could contribute to recurrent MI within 6 months.

1. Kounis NG, Koniari I, Velissaris D, et al. Kounis Syndrome — not a Single-organ Arterial Disorder but a Multisystem and Multidisciplinary Disease. Balkan Med J. 2019;36:212-21. doi:10.4274/balkanmedj.galenos.2019.2019.5.62.

2. Roumeliotis A, Davlouros P, Anastasopoulou M, et al. Allergy Associated Myocardial Infarction: A Comprehensive Report of Clinical Presentation, Diagnosis and Management of Kounis Syndrome. Vaccines. 2022;10(1):38. doi:10.3390/vaccines10010038.

3. Li J, Zheng J, Zhou Y, et al. Acute coronary syndrome secondary to allergic coronary vasospasm (Kounis Syndrome): a case series, follow-up and literature review. BMC Cardiovascular Disord. 2018;18(1):42. doi:10.1186/s12872-018-0781-9.

4. Kalatsei LV, Snezhitskiy VA, Hrib SN, et al. Clinical case of allergic acute cononary syndrome (Kounis syndrome) caused by cold urticaria. Journal of the Grodno State Medical University. 2021;19(2):229-35. (In Russ.) doi:10.25298/2221-8785-2021-19-2-229-235.

5. Kowalski ML, Agache I, Bavbek S, et al. Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)-a EAACI position paper. Allergy. 2019;74(1):28-39. doi:10.1111/all.13599.

6. De VA, Kochetkov AI, Kogai VV, et al. Drug-induced Asthma Exacerbations and Bronchospasm. Lechebnoe delo. 2021;(4):17-23. (In Russ.) doi:10.24412/2071-5315-2021-12388.

7. Hokimoto S, Kaikita K, Yasuda S, et al. JCS/CVIT/JCC 2023 guideline focused update on diagnosis and treatment of vasospastic angina (coronary spastic angina) and coronary microvascular dysfunction. Circ J. 2023;87:879-936. doi:10.1253/circj.CJ-22-0779.

8. Boldueva SA, Leonova IA. Primary microvascular angina (cardiac syndrome X). Controversial and unresolved issues: terminology, definitions, pathogenetic mechanisms. Heart. 2016;15(4):223-34. (In Russ.) doi:10.18087/rhj.2016.4.2196.

9. Guzeva VM, Yarmosh IV, Evdokimov DS, еt al. Features of endothelial function and autonomic regulation of heart rhytm in patients with vasospastic angina. I.I. Mechnikov Herald of North-Western State Medical University. 2021;13(4):71-8. (In Russ.) doi:10.17816/mechnikov80403.

10. Leonova IA, Zakharova OV, Boldueva SA. Disorders of endothelium-dependent vasodilation in patients with microvascular angina. Russian Medical Inquiry. 2022;6(8): 427-32. (In Russ.) doi:10.32364/2587-6821-2022-6-8-427-432.

11. Shaw KM, Neaves BI, Springer HA, et al. A Complicated Case of Aspirin-Exacerbated Respiratory Disease With Kounis Syndrome. Cureus. 2023;15(9):e45635. doi:10.7759/cureus.45635.

12. Hamdi I, Chourabi C, Jabloun TY, et al. Samter—Beer triad presenting as Kounis type I variant of syndrome. J Saudi Heart Assoc. 2018;30(3):290-3. doi:10.1016/j.jsha.2018. 03.002.

13. Takahashi J, Onuma S, Hao K, et al. Pathophysiology and diagnostic pathway of myocardial infarction with non-obstructive coronary arteries. J Cardiol. 2024;83:17-24. doi:10.1016/j.jjcc.2023.07.014.

14. Beltrame JF, Crea F, Kaski JC, et al. Coronary Vasomotion Disorders International Study Group (COVADIS). International standardization of diagnostic criteria for vasospastic angina. Eur Heart J. 2017;38(33):2565-8. doi:10.1093/eurheartj/ehv351.

15. Xu SW, Ilyas I, Weng JP. Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies. Acta Pharmacol Sin. 2023;44(4):695- 709. doi:10.1038/s41401-022-00998-0.